Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 23/09/2011
PIL Prempak-C

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 25/08/2011 and displayed until 23/09/2011
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 14/03/2011 and displayed until 25/08/2011
Reasons for adding or updating:
  • Change of contra-indications
Updated on 17/08/2010 and displayed until 14/03/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 15/07/2010 and displayed until 17/08/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 31/03/2010 and displayed until 15/07/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
Updated on 29/05/2009 and displayed until 31/03/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 22/08/2008 and displayed until 29/05/2009
Reasons for adding or updating:
  • Change to instructions about overdose
Updated on 06/06/2008 and displayed until 22/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 14/09/2007 and displayed until 06/06/2008
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change of inactive ingredient
  • Change to date of revision
Updated on 10/02/2006 and displayed until 14/09/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to how the medicine works
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 27/06/2005 and displayed until 10/02/2006
Reasons for adding or updating:
  • Change to storage instructions
  • Change from BAN to rINN
  • Change to date of revision
Updated on 20/02/2004 and displayed until 27/06/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 30/09/2003 and displayed until 20/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 08/07/2002 and displayed until 30/09/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  norgestrel
  oestrogens, conjugated